MICHAEL ROSS

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: ROSS

Related Companies
Titles
Company Name
Related People
DIRECTOR
CERVILENZ INC
KEVIN BRAMER, RYAN CARUSO, JENNIFER COLEMAN, GEORGE DUNBAR, KOLEMAN KARLESKI, DEAN KOCH, KARLESKI KOLEMAN, SUSAN LURIA, EILEEN MAUS, FEDERICA O-BRIEN, TIMOTHY PETERSEN, TIMOTHY PETERSEN PETERSEN, TIMOTHY PETERSON, W. EARL REED, III, DOUG ROHALL, MEG RUSH, TOM SHEHAB, WRIGHT STEENROD
DIRECTOR
JUVARIS BIO THERAPEUTICS INC
CAROL L. BROSGART, KIMBERLEE GONZAGA, THOMAS P. MONATH, GRANT E. PICKERING, LEWIS T. WILLIAMS
DIRECTOR
IKANO THERAPEUTICS INC.
G. STEVEN BURRILL, PAT FABBIO, BRUCE PEACOCK, JAMES TULLIS, ROBERT WEISSKOFF, PETER YOUNG
DIRECTOR
ADIMAB, INC.
ERRIK B. ANDERSON, ROBERT L. BIRNBAUM, TILLMAN U. GERNGROSS, BILL MARIS, WILLIAM J. MARIS, TERRANCE MCGUIRE
EXECUTIVE OFFICER
SV LIFE SCIENCES FUND V LP
KATE BINGHAM, JAMES GARVEY, LUTZ GIEBEL, EUGENE D. HILL, III, DAVID MILNE, N/A SV LIFE SCIENCES FUND V (GP), L.P., N/A SVLSF V, LLC
DIRECTOR
LINK MEDICINE CORP
JOHN F. DEE, MICHAEL E. FITZGERALD, DAVID FRANKEL, NICK GALAKATOS, DAVID GUYER, PETER T. LANSBURY, R. MICHAEL POOLE, EDWARD SCOLNICK, MICHAEL E. SOLOMON
DIRECTOR
CATABASIS PHARMACEUTICALS INC
KENNETH BATE, JOANNE T. BECK, FRED CALLORI, NOAH CLAUSER, HUGH COLE, JOANNE C. DONOVAN, NICHOLAS GALAKATOS, JEAN GEORGE, BEN HARSHBARGER, MICHAEL JIROUSEK, MICHAEL D. KISHBAUCH, ANDREW KOMJATHY, GREGG LAPOINTE, RON LAUFER, MAGGIE LEFLORE, JEFFREY LEIDEN, JILL MILNE, JILL C. MILNE, ANDREW NICHOLS, IAN C. SANDERSON, CHRIS THOMAJAN, CHRISTOPHER Z. THOMAJAN, JONATHAN VIOLIN
EXECUTIVE OFFICER
SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.
KATE BINGHAM, JAMES GARVEY, LUTZ GIEBEL, EUGENE D. HILL, III, DAVID MILNE, N/A SV LIFE SCIENCES FUND V (GP), L.P., N/A SVLSF V, LLC
DIRECTOR
ARSANIS, INC.
JAN ADAMS, WILLIAM ALISKI, WILLIAM E. ALISKI, ERRIK B ANDERSON, ERRIK B. ANDERSON, CHRISTOPHE ARBET-ENGELS, MARK BALDRY, ROBERT L. BIRNBAUM, GARY BRIDGER, GARY J. BRIDGER, DAN BURGESS, DANIEL BURGESS, DIEGO CADAVID, WILLIAM CLARK, ADAM CRAIG, FRANCOISE DE CRAECKER, MARY DIBIASE, TILLMAN GERNGROSS, TILLMAN U GERNGROSS, TILLMAN U. GERNGROSS, CARL GORDON, MICHAEL GRAY, DAVID KIRSKE, ALISON LAWTON, DAVID MANTUS, DAVID MCGIRR, TERRANCE MCGUIRE, DEREK MEISNER, ADAM MOSTAFA, ADAM S. MOSTAFA, ESZTER NAGY, CLAUDIO NESSI, PAULA RAGAN, RENE RUSSO, AMY SCHULMAN, CHRIS STEVENS, MURRAY STEWART, MURRAY W. STEWART, ARTHUR TAVERAS, JOHN VOLPONE, MICHAEL WYZGA, MICHAEL S. WYZGA
DIRECTOR
BALANCE HEALTH CORP
JAY GARCIA, ALEXANDER HERN, RIVERSON LEONARD
DIRECTOR
ABCAM PLC
PETER VANCE ALLEN, MARA GLICKMAN ASPINALL, MICHAEL SHAUN BALDOCK, TIM DYE, MURRAY HENNESSY, ALAN THOMAS HIRZEL, JEFF ILIFFE, JEFF ILIFFEE, PETER KEEN, GILES FRANCIS BERTRAM KERR, TONY KOUZARIDES, ANTHONY MARTIN, JONATHAN MILNER, JONATHAN SIMON MILNER, LOUISE ALEXANDRA VIRGINIA CHARLOTTE PATTEN, MICHAEL REDMOND, MIKE REDMOND, DAVID JAMES WARWICK, JIM WARWICK, MARK WEBSTER
DIRECTOR
ADIMAB, LLC
ERRIK B. ANDERSON, ROBERT L. BIRNBAUM, TILLMAN U. GERNGROSS, FRAN HELLER, WILLIAM J. MARIS, TERRANCE MCGUIRE
DIRECTOR
AVITIDE, INC.
ERRIK ANDERSON, PHILIP FERNEAU, TILLMAN GERNGROSS, COLIN GREENSPON, RISHI GUPTA, KEVIN ISETT, KEVIN ISSETT, SCOTT KENNEDY, WARREN KETT, CLAUDIO NESSI, IAN RATCLIFFE, AJAY ROYAN, JON SHELLER, JONATHAN SHELLER
DIRECTOR
OPHTHOTECH CORP.
THOMAS BIANCARDI, ALEX BOLTE, AXEL BOLTE, DAVID CARROLL, THOMAS DYRBERG, NICHOLAS GALAKATOS, LUTZ GIEBEL, DAVID GUYER, EVELYN HARRISON, JANE PRITCHETT HENDERSON, SAMIR C. PATEL, BRUCE PEACOCK, DAVID REDLICK, GLENN SBLENDORIO, HENRY SIMON, KEITH WESTBY
DIRECTOR
THESAN PHARMACEUTICALS, INC.
METTE AGGER, TIBA AYNECHI, PETER BISGAARD, GIOVANNI FERRARA, JOHN GORDON FOULKES, ED MONAGHAN, HENRY SKINNER, HOWARD WELGUS
EXECUTIVE OFFICER
SV LIFE SCIENCES FUND VI, L.P.
KATE BINGHAM, THOMAS FLYNN, JAMES GARVEY, EUGENE HILL, PAUL LAVIOLETTE, DAVID MILNE, N/A SV LIFE SCIENCES FUND VI (GP), L.P., N/A SVLSF VI, LLC
DIRECTOR
DECIPHERA PHARMACEUTICALS, LLC
PATRICIA L. ALLEN, EDWARD J. BENZ, JR., JAMES A. BRISTOL, PH.D., DANIEL F. FLYNN, PH.D., DANIEL L. FLYNN, PH.D., THOMAS KELLY, JOHN MARTIN, CHRISTOPHER J. MORL, LIAM RATCLIFFE, M.D., PH.D., OLIVER ROSEN, M.D., MICHAEL TAYLOR, MICHAEL D. TAYLOR, PH.D., DENNIS WALSH
EXECUTIVE OFFICER
DEMENTIA DISCOVERY LP
LAURENCE BARKER, CATHERINE BINGHAM, HAMISH CAMERON, N/A DEMENTIA DISCOVERY GENERAL PARTNER LLP, N/A DEMENTIA DISCOVERY GP LP, TETSUYUKI MARUYAMA, N/A SV HEALTH MANAGERS LLP, N/A SV LIFE SCIENCES MANAGERS LLP
EXECUTIVE OFFICER, DIRECTOR
AMERICLEAN HOLDINGS LLC
STEVEN C. LABARRE, MARK R. MCCAMMON
EXECUTIVE OFFICER
SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.
KATE BINGHAM, THOMAS FLYNN, JAMES GARVEY, EUGENE HILL, PAUL LAVIOLETTE, N/A SV LIFE SCIENCES FUND VI (GP), L.P., N/A SVLSF VI, LLC
DIRECTOR
FRESCO FOODS, INC.
ROBERT POVOLNY, TRACY POVOLNY
DIRECTOR
SUTRO BIOPHARMA INC
MICHAEL DYBBS, JOHN G. FREUND, DANIEL JANNEY, BRYAN LAWLIS, VIRGIL BRYAN LAWLIS, JOSEPH LOBACKI, WILLIAM J. NEWELL, DANIEL PETREE, ARMEN SHANAFELT
DIRECTOR
RIBOMETRIX, INC.
MICHAEL DIAL, MIKE DIAL, HAKAN GOKER, JOHN GUSTOFSON, WILLIAM MARSHALL, JOSHUA RESNICK, MICHAEL SOLOMON, KATHERINE WARNER, KEVIN WEEKS
EXECUTIVE OFFICER
JASON RYAN
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NICE RECOVERY SYSTEMS LLC
GREGG BAGNI, ROBERT E. GLANVILLE, TOM HACKETT, DENNIS JENSON, GRANT KASHNER, JOEL MEISINGER, BRIAN WATSON
DIRECTOR
THERINI BIO, INC.
AIKATERINI AKASOGLOU, HOUMAN ASHRAFIAN, LAURENCE BARKER, DANIEL BURGESS, DANIEL D BURGESS, LAIA CRESPO-MARTIN, OLGA DANILCHANKA, DAVID DOLBY, TARA NICKERSON, MICHAEL QUIGLEY, TRACY SAXTON, LESLIE SCHULZE, EDWARD SPACK, JEFFREY STAVENHAGEN, JEFFREY STAVENHAGEN, PH.D.
EXECUTIVE OFFICER
MAINE CRISP COMPANY, LLC
KAREN GETZ, STEPHEN GETZ
EXECUTIVE OFFICER, PROMOTER
JOSEPH VENTURES ALLIUM I LLC, SERIES A
DIRECTOR
XILIO THERAPEUTICS, INC.
TIMOTHY CLACKSON, PAUL CLANCY, DANIEL CURRAN, PETER DUDEK, JOSEPH FARMER, DAVID GARDNER, DAVID GRAYZEL, ANDREW HACK, NANCY HONG, RACHEL HUMPHREY, DANIEL LYNCH, RENE RUSSO, ROBERT WEISSKOFF
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JOSEPH VENTURES ALLIUM I LLC, SERIES C
EXECUTIVE OFFICER
SV LIFE SCIENCES FUND IV CF, L.P.
HOUMAN ASHRAFIAN, MICHAEL BALMUTH, KATE BINGHAM, THOMAS FLYNN, EUGENE HILL, PAUL LAVIOLETTE, GREG MADDEN, N/A SV LIFE SCIENCES FUND IV CF (GP), LLC
DIRECTOR
ANDOVIA INC.
DAVID MAGNAN, JUSTIN MAGNAN
DIRECTOR
TREX HOLDINGS INC.
MICHAEL BARAN, ALEXANDRA CANTLEY, TRAVIS COY, M. JOHNSTON ERWIN JR., CAROL GALLAGHER, PETER HIRTH, ERIC HUANG, JOEL MARCUS, SANJAY MISTRY, ERIC PHAM, NIKOLA TRBOVIC
DIRECTOR
DUALITAS THERAPEUTICS, INC.
FORBES HUANG, THOMAS HUDSON, GREG LAZAR, ALICIA LEVEY, MARK MCDADE, RICHARD MURRAY, NIKOLA TRBOVIC, NEIL WEIR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-07 
2025-09-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-03-29 
2024-11-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-11-07 
2024-09-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-30 
2023-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-03-29 
2023-02-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-02-01 
2022-03-25
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-08-13 
2021-07-22
D
Link
 
 
NO REVENUES 
 
2021-07-07 
2021-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-23 
2021-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-20 
2020-11-18
D
Link
 
 
NOT APPLICABLE 
Equity 
2020-11-02 
2020-11-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2020-10-13 
2020-05-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-08 
2019-10-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-09 
2019-09-24
D
Link
OTHER REAL ESTATE 
 
NO REVENUES 
Equity 
2018-11-13 
2018-11-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-05 
2018-11-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-10-30 
2018-08-08
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-05-24 
2018-06-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-05-24 
2017-12-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-05 
2017-12-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-11-20 
2017-10-17
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2015-10-16 
2017-06-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-13 
2017-06-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-26 
2017-05-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-24 
2017-04-12
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-03-31 
2016-10-17
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2015-10-16 
2016-10-14
D/A
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-01 
2016-07-14
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-14 
2016-05-26
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2015-05-28 
2016-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-04-12 
2015-12-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-16 
2015-11-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-10 
2015-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-23 
2015-06-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
2015-03-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-17 
2014-08-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
2014-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-27 
2014-02-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-11 
2013-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-31 
2013-08-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
2013-06-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-18 
2013-06-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-23 
2013-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-04 
2013-02-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-18 
2013-01-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-07 
2012-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-19 
2012-04-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-16 
2012-02-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-09 
2011-10-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-28 
2011-04-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-04-07 
2011-02-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-31 
2010-11-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-22 
2010-11-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-15 
2010-10-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-10-12 
2010-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-15 
2010-07-23
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-17 
2010-07-15
D
Link
HOSPITALS AND PHYSICIANS 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-17 
2010-04-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-21 
2010-04-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-07 
2010-04-07
D
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2010-03-26 
2010-03-10
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2009-03-27 
2009-12-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-25 
2009-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-11 
2009-05-18
D
Link
HOSPITALS AND PHYSICIANS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-30